Synelvia is a renowned brand specializing in CRO (Contract Research Organization) studies and preclinical research in the fields of pharmacology, dermatology, and cosmetics. With a commitment to responsible and ethical practices, Synelvia offers a wide range of products and services to support in vivo testing alternatives. Their expertise includes in silico testing, chemoinformatics, phytochemical and metabolic profiling, as well as in vitro and ex vivo testing.

Synelvia also provides services in cellular and tissue engineering, histology, sample preparation, and imaging techniques such as electron microscopy and scanning of slides. For the cosmetic industry, Synelvia offers solutions in hydration and skin barrier, epidermal regeneration, firmness and cohesion of the skin, anti-aging, and skin defense. They also specialize in pigmentations, oily and seborrheic skin, microbiome studies, and slimming and adipocyte metabolism.

In the field of dermatology, Synelvia focuses on skin conditions including acne, alopecia, scar healing, atopic dermatitis, psoriasis, melanoma, and vitiligo. They also cater to the pharmaceutical industry with expertise in immuno-inflammation, cancer research, neurobiology, and veterinary medicine. With their unwavering commitment to quality and innovation, Synelvia's dedicated teams at QIMA Life Sciences are at the forefront of advancing research and development in the industry